You are here: Industry Insights > antibody

News List

Research Progress on the Mechanisms of Immunomodulatory Effects of Plant Polysaccharides (Part I) Xiaonisha
September 08, 2025
Plant polysaccharides, abbreviated as PPS, are compounds composed of many identical or different monosaccharides linked by α- or β-glycosidic bonds.
Advances in the Research of Targeting B Cells for the Treatment of Systemic Lupus Erythematosus Xiaonisha
July 25, 2025
Systemic Lupus Erythematosus (SLE) is a chronic, systemic autoimmune disease. The direct cause of SLE pathogenesis lies in the immune imbalance resulting from excessive B-cell activation.
Research and Development Status and Progress of Antibody Technology (Part Ⅱ) Xiaomichong
July 18, 2024
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
Research and Development Status and Progress of Antibody Technology (Part I) Xiaomichong
July 18, 2024
Antibody-based biological therapeutic drugs have been playing an increasingly important role in biopharmaceuticals due to their strong targeting, good specificity, and significant therapeutic effects.
How is the progress of China’s domestically produced PD-(L)1 “going global”? Yefenghong/PharmaSources
November 23, 2023
Recently, Coherus BioSciences announced that the FDA has approved the launch of PD-1 antibody toripalimab (marketed jointly by Junshi Biosciences and Coherus) for use in combination with gemcitabine/cisplatin as a first-line treatment for advanced recurre
A comprehensive review of the currently marketed ADC drugs: the industry maintains high prosperity WND
November 07, 2023
Antibody-drug conjugates (ADCs) are a class of drugs composed of antibodies targeting tumor antigens and a variable number of small molecule toxins linked through connectors.
Research Progress on the Application of Biologics in Childhood Asthma. Xiaomichong
October 30, 2023
Asthma is a heterogeneous, complex chronic disease. Children with severe asthma often experience acute exacerbations, leading to impaired lung function and poor quality of life.
Pharmaceutical Business Progress in China and Worldwide (March) PharmaSources
May 12, 2023
Progress in Pharmaceutical Business at Home and Abroad (March)
Weekly Pharma News Review | PharmaSources.com (March 21 to 25) PharmaSources/Caicai
March 30, 2022
Henlius PD-1 was launched this week, becoming the 7th China-made PD-1 monoclonal antibody and the 13th PD-1/PD-L1 monoclonal antibody that was marketed in China.
Antibody-Drug Conjugates – Understanding the "Trojan Horses" Neeta Ratanghayra
May 31, 2021
A robust strategy for targeted therapy, known as antibody-drug conjugates (ADCs), has been developed to counterfeit this challenge.